Columns

EN

2026.04.11

Japan-Only Orphan Drugs Available for Export: A Guide for Rare Disease Treatment Centres

A guide for rare disease treatment centres and hos...

Read More

EN

2026.04.11

Chenodeoxycholic Acid from Japan: Sourcing Guide for Rare Disease Clinics

A sourcing guide for rare disease clinics seeking ...

Read More

EN

2026.04.11

Sourcing Lidocaine from Japan: Options for International Healthcare Buyers

A guide for international healthcare buyers on sou...

Read More

EN

2026.04.11

Japanese Orphan Drugs for Neurological Conditions: What Is Available for Export

A guide for specialist neurology departments and r...

Read More

EN

2026.04.11

Meropenem and Japanese Antibiotics: A Procurement Guide for International Buyers

A procurement guide for international hospital buy...

Read More

EN

2026.03.07

Rejuran Types Explained: HB, i, s Differences, Usage, and Parallel Imports | TASAKI PHAMA

A thorough explanation of the differences between ...

Read More

EN

2026.03.07

High-Concentration Minoxidil Import: Safe Use of Topical Solutions Over 15% | TASAKI PHAMA

For those considering importing high-concentration...

Read More

EN

2026.03.07

NAD+ IV Drip Import: Latest Information on US Formulations Safety and Vascular Pain Risk | TASAKI PHAMA

[Latest] Information regarding the import of NAD+ ...

Read More

EN

2026.03.07

LHALALA Peel Introduction: No-Downtime 4th Generation Peeling – Guide for Aesthetic Dermatology Clinics | TASAKI PHAMA

For aesthetic dermatologists considering introduci...

Read More